3 Recruiting HER2-positive Breast Cancer Phase 3 Clinical Trials
Active phase 3 studies for her2-positive breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All HER2-positive Breast Cancer studiesPhase 3 Studies for HER2-positive Breast Cancer
🔵 Active, Not Recruiting Phase3
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
📍 University of South Alabama Health Children's and Women's Hospital — Mobile, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
📍 Cancer Center at Saint Joseph's — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
📍 The West Clinic, PC dba West Cancer Center — Germantown, Tennessee
View Study & Checklist ➔